Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis.
Smolen
Josef S
JS
Division of Rheumatology, Medical University of Vienna, Vienna, Austria. josef.smolen@meduniwien.ac.at
Aletaha
Daniel
D
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D015201:Meta-Analysis as Topic; D012196:Review Literature as Topic; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha